Companies in the biopharma sector developing innovative solutions and technologies.
Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.
Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients
B1 Health offers a platform for clinical trial design optimization, documentation, process tracking & insight generation for biotech firms.
Nuvectis Pharma is a biopharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer.
FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.
Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs.
Rapalogix Health is a biotechnology company focused on developing longevity-based solutions for skin health and dermatological conditions.
Houdini Bio develops computational synthetic biology tools to redesign DNA constructs for improved genetic medicines.
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
FinalDose develops programmable DNA therapeutics that eliminate diseased cells by targeting pathogenic genetic sequences.
MultiValent Biotherapies is a biotechnology company.
Naturmet develops and operates biomethane production plants in Spain.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.
City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.
Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.
ME Therapeutics is a biotechnology company that focuses on discovery & development of myeloid cell targeted immuno oncology drugs.
NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.
Mammogen specializes in improving the detection, diagnosis, and treatment of breast cancer, from end-to-never-end.
Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.
Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked